ArticleFrontiers in oncology2022

Verification and Validation of a Four-Gene Panel as a Prognostic Indicator in Triple Negative Breast Cancer.

Mamta Pariyar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.